KRAS oncogene is a critical driver of tumorigenesis in several malignancies. The KRAS G12C mutation is present in about 14% of non-small-cell lung cancer (NSCLC) cases. Mechanistically, this mutation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results